Advanced Pharma Inc., of Gaithersburg, Md., appointed Gordon Douglas and Wayne Hockmeyer to its board.

Alkermes Inc., of Cambridge, Mass., appointed David Broecker chief operating officer and promoted Duncan Higgons to senior vice president, proprietary products.

AlphaRx Inc., of Richmond Hill, Ontario, appointed Peter Carlen to its advisory board.

Antisoma plc, of London, appointed Adam Craig medical adviser, oncology.

Avidex Ltd., of Oxford, UK, appointed Peter Doyle and Alan Rosenthal nonexecutive directors.

Battelle Pulmonary Therapeutics Inc., of Columbus, Ohio, added Aleksandar Erdeljan, Wilbur Gantz and Robert Towarnicki to its board.

Bio-Gen-Tec-NRW e.V., of Cologne, Germany, appointed Hartmut Thomas CEO.

Cerus Corp., of Concord, Calif., appointed James Vaughn vice president, marketing.

Connetics Corp., of Palo Alto, Calif., added Linda Fenney as senior vice president of clinical research for relaxin, and named Gregory Vontz chief operating officer.

diaDexus Inc., of Santa Clara, Calif., appointed Nathan Letts director, intellectual property and Maureen Wang director, molecular biology.

Durect Corp., of Cupertino, Calif., appointed Armand Neukermans to its board.

Dynamis Therapeutics Inc., of Wyndmoor, Pa., named Michael Schwartz director of scientific operations.

Endorex Corp., of Chicago, named John McCracken vice president, business development.

Exact Sciences Corp., of Maynard, Mass., added Amy Hedison as director of investor relations.

Genentech Inc., of South San Francisco, promoted Robert Garnick to senior vice president, regulatory, quality and compliance.

Genzyme Biosurgery, a division of Genzyme Corp., of Cambridge, Mass., named Ann Merrifield executive vice president.

Genzyme Corp., of Cambridge, Mass., elected former U.S. Senator Connie Mack to its board.

Immtech International Inc., of Vernon Hills, Ill., appointed Mary Garcia director of Intranet drug development networking program and Lisa McChesney-Harris director of pharmaceutical development.

Immunex Corp., of Seattle, added Efi Cohen-Arazi as senior vice president of supply operations and Michael Aguiar as vice president of finance, and promoted Deborah Helleson to vice president of business development.

Magainin Pharmaceuticals Inc., of Plymouth Meeting, Pa., appointed Michael Yoshitsu vice president, business development and promoted Kenneth Holroyd to executive vice president and chief business officer.

MediChem Life Sciences Inc., of Chicago, appointed Rajni Aneja vice president, corporate development; Stephen Wasserman senior director, synchrotron services; and Premchandran Ramiya director of process research and development.

Medicure Inc., of Winnipeg, Manitoba, appointed Karl-Gunnar Hidinger vice president, clinical development.

Nautilus Biotech, of Paris, added Christian Freier as director of business development.

NeoTherapeutics Inc., of Irvine, Calif., hired Frank Chiu as director, biostatistics and data management.

NeuralStem Biopharmaceuticals Ltd., of College Park, Md., filled five positions: Judith Kelleher-Andersson is now director of neuropharmacology; Babru Samal is principal scientist, gene discovery; Allison Formal is vice president, worldwide business development; Hoyt Matthai is director of manufacturing; and Kathleen Mattis is vice president, finance.

NewBiotics Inc., of San Diego, added Lorna Speid as vice president of regulatory affairs and project management and Thomas Lobl as vice president of drug discovery.